Home›Desmopressin›Legal status
Educational — Not Legal AdviceReviewed
Is Desmopressin legal? FDA status and US regulatory standing
Current status
FDA-approved. Desmopressin is an FDA-approved drug (status recorded ).
Primary source: www.accessdata.fda.gov
Federal legal status
FDA approval status
Desmopressin is an FDA-approved drug. FDA-approved synthetic vasopressin analog. Brands: DDAVP (NDA 017922), Stimate, Nocdurna (NDA 201532, Jun 2018). Approved forms: injection, intranasal, oral, sublingual. Prescription only.
Also known as
DDAVP · dDAVP · Minirin · Stimate
Status history
- Desmopressin is an FDA-approved drug. [source]
Frequently asked questions
- Is Desmopressin FDA approved?
- Desmopressin is an FDA-approved drug (status recorded 1978-01-01). Primary source linked on this page.
- Can doctors prescribe Desmopressin?
- Desmopressin is listed as prescription-availability in the PeptideBase library. Prescribing rules vary by state and prescriber licensure — consult a licensed clinician.
PeptideBase provides educational research tools and provider discovery. It does not provide medical advice, diagnosis, treatment, prescribing guidance, or dosing instructions. Consult a qualified healthcare professional before making health decisions.
Content review: Regulatory status is sourced from the linked primary records and reviewed by the PeptideBase editorial team. This page is educational — not legal or medical advice. Last reviewed: .